CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

Seraclone Blood Grouping Reagents and Anti-Human Globulin Reagents (STN# 125213, 125215, 125217, 125219 - 125233, 125242)

RegulatoryapprovedSeraclone Blood Grouping Reagents and Anti-Human Globulin ReagentsPositive
AI Analysis

Summary

Seraclone Blood Grouping Reagents and Anti-Human Globulin Reagents received FDA approval for determining blood group antigens and detecting red blood cell coating using tube test methodology.

Outcome Details

FDA approval for blood grouping reagents and anti-human globulin reagents for tube test use

Importance:4/10
Sentiment:
0.70
FDA approvaldiagnosticsblood bankingreagents

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on August 26, 2026 7:59 PM

Read Original